Charles Schwab MD disposes 3,205 SCHW shares via Rule 10b5-1 plan
Rhea-AI Filing Summary
The Charles Schwab Corporation insider reported a planned sale of shares under a Rule 10b5-1 plan. On 09/02/2025 the reporting person sold 3,205 shares of SCHW at a weighted average price of $95.2033 per share, with execution prices reported between $95.04 and $95.29. The Form 4 lists the reporting person as MD, Chief Banking Officer and indicates continued indirect beneficial ownership of 37,983.1078 shares held by a trust. The filing notes the sales were made pursuant to a 10b5-1 plan adopted on November 15, 2024, and the Form 4 was signed by an attorney-in-fact on 09/03/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sold a small block via a pre-established 10b5-1 plan; remaining indirect holdings persist.
The transaction is a routine, pre-planned disposition: 3,205 shares were sold at a weighted average of $95.2033 between $95.04 and $95.29. The sale was executed under a Rule 10b5-1 trading plan adopted 11/15/2024, which provides affirmative defense for scheduled trades. Post-transaction indirect beneficial ownership is shown as 37,983.1078 shares held by a trust. From an analyst perspective this filing documents a controlled liquidity event rather than a governance shock or abrupt change in ownership.
TL;DR: Filing reflects compliance with insider-trading protocols; no new governance issues disclosed.
The Form 4 discloses that the reporting person used a Rule 10b5-1 plan to effect sales, and the filer certified willingness to provide trade-level details on request. The signature by an attorney-in-fact indicates procedural completion. There are no disclosed departures, appointments, or other governance actions in this filing; it is limited to scheduled equity disposition and updated beneficial ownership figures.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,205 | $95.2033 | $305K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024. This transaction was executed in multiple trades at prices ranging from $95.04 to $95.29. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.